Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo

Transplantation

Volumn 67, Issue 9, 1999, Pages 1284-1287

  Förster, Elisabeth ^a   Krenger, Werner ^a   Joergensen, Joanne ^b   Hof, Robert ^b   Geha, Raif S ^c   Hollander, Georg A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; ANTIGENS, CD80; B-LYMPHOCYTES; CD40 LIGAND; EPITOPES, T-LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERCELLULAR ADHESION MOLECULE-1; ISOANTIBODIES; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES;

EID: 0344848799     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905150-00016     Document Type: Article

References (15)

1. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111.
2. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
3. Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 1995; 25: 596.
4. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 1996; 14: 591.
5. Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997; 9: 641.
6. Holländer GA, Castigli E, Kulbacki R, et al. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci USA 1996; 93: 4994.
7. Castigli E, Alt FW, Davidson L, et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 1994; 91: 12135.
8. Krieger JI, Grammer SF, Grey HM, Chesnut RW. Antigen presentation by splenic B cells: resting B cells are ineffective whereas activated B cells are effective accessory cells for T cell responses. J Immunol 1985; 135: 2937.
9. Corry RJ, Winn HJ, Russell PS. Primary vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
10. Chitilian HV, Auchincloss H. The indirect pathway in graft rejection. Curr Opin Organ Transplant 1997; 2: 3.
11. Niimi M, Pearson TC, Larsen CP, et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 1998; 161: 5331.
12. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
13. Mach F, Schonbeck U, Sukhova G, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931.
14. Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591.
15. Brändle D, Joergensen J, Zenke G, Bürki K, Hof RP. Contribution of donor-specific antibodies to allograft rejection: evidence from B-cell deficient mice. Transplantation 1998; 65: 1489.